MPs push SHA cover for haemophilia clotting treatment
Key points
- MPs are pushing SHA benefits to include haemophilia treatment such as clotting factor infusions.
- Proposed packages may also touch specialist consults and hospital care for bleeds.
- For families, coverage can mean the difference between timely treatment and lifelong disability risk.
Rare does not mean optional. Nation.Africa reports legislators are pushing the Social Health Authority (SHA) to cover treatment for haemophilia — including clotting factor infusions, specialist consultations and hospital care for bleeds.
Haemophilia patients can face sudden, expensive medical crises. Without insurance cover for clotting factors, families ration doses, delay hospital visits, or fall into debt. A benefit package that names these services would move Kenya closer to treating bleeding disorders as a financed health right rather than a private tragedy.
What SHA inclusion would change
Coverage design matters: which factors, which ages, which facilities, and whether prior authorisation blocks emergencies. If the package is too narrow, patients still pay out of pocket. If it is broad but poorly funded, hospitals stock out.
Advocates will also watch whether SHA pairs financing with specialist training outside Nairobi, so patients in counties are not forced into overnight buses for every bleed.
Next steps
Parliamentary petitions and ministry responses should be published so patients can track commitments. Until then, families should keep medical records organised and engage patient groups for guidance on current access programmes.
Health agencies: government directory.
Based on public health/policy reporting. Confirm final SHA benefit schedules officially.